Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 4,700 shares at $44.43 ($209K) on 2011-12-06, disclosed to the SEC on 2011-12-08.
Open-market sale of $209k SLXP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | BUY | 2011-08-11 | $21K | — | Filing → |